What are the current GOLD guidelines criteria for prescribing LTOT in stable COPD? Specifically, what PaO2 and SpO2 thresholds trigger initiation, how many hours/day should it be used, and does it improve survival in all COPD patients or only specific subgroups (e.g., those with resting hypoxemia vs exercise-induced desaturation)?
For peer discussion only — not a substitute for clinical judgment. Verify with authoritative sources.
0
0 answers0 Answers
💬
No answers yet
Be the first to share your clinical insight.
Your Answer
Be specific. Your credentials will be shown with your answer.
References (strongly recommended)
Answers with guideline links, journal citations, or textbook references are more trusted by the community.